Literature DB >> 20526577

Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes.

T Vepsäläinen1, M Soinio, S Lehto, A Juutilainen, M Laakso, T Rönnemaa.   

Abstract

AIMS/HYPOTHESIS: Physical activity reduces cardiovascular disease (CVD) and total mortality rates in patients with type 2 diabetes. However, it is not known whether or not the effects of physical activity on mortality rates depend on the presence of proteinuria in type 2 diabetic patients.
METHODS: We prospectively followed up 577 patients with type 2 diabetes who were aged 45 to 64 years and were free of CVD at baseline. Participants were stratified according to the presence of proteinuria (<or=300 or >300 mg/l) and the degree of physical activity (0-4 metabolic equivalent tasks [MET] or >4 MET). The Cox proportional hazards model was used to estimate the association of physical activity and proteinuria with risk of mortality.
RESULTS: During the 18-year follow-up, 356 patients died, of whom 217 died from CVD. Physically more active patients had significantly reduced total, CVD and CHD mortality rates if they did not have proteinuria. In contrast, physically active proteinuric patients had significantly increased total and CVD mortality rates (HR 1.83, 95% CI 1.00-3.36, p=0.049) in univariate analyses, with HR 2.43 (95% CI 1.09-5.40, p=0.030) in multivariate analyses. CONCLUSIONS/
INTERPRETATION: Physical activity reduces total and CVD mortality rates in type 2 diabetic patients without proteinuria. However, in proteinuric patients, no protective effect was observed. Larger studies are needed to confirm the latter finding and to define which exercise intensity leads to possible harmful effects.

Entities:  

Mesh:

Year:  2010        PMID: 20526577     DOI: 10.1007/s00125-010-1812-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.

Authors:  Thomas H Marwick; Matthew D Hordern; Todd Miller; Deborah A Chyun; Alain G Bertoni; Roger S Blumenthal; George Philippides; Albert Rocchini
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

2.  Assay for protein by dye binding.

Authors:  H van Kley; S M Hale
Journal:  Anal Biochem       Date:  1977-08       Impact factor: 3.365

3.  Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.

Authors:  H Miettinen; S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

4.  Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.

Authors:  Emina Colak; Nada Majkić-Singh; Sanja Stanković; Vesna Srecković-Dimitrijević; Predrag B Djordjević; Katarina Lalić; Nebojsa Lalić
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

Review 5.  Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy?

Authors:  Georg Kojda; Rainer Hambrecht
Journal:  Cardiovasc Res       Date:  2005-08-01       Impact factor: 10.787

6.  Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men.

Authors:  S N Blair; H W Kohl; C E Barlow; R S Paffenbarger; L W Gibbons; C A Macera
Journal:  JAMA       Date:  1995-04-12       Impact factor: 56.272

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

8.  Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes.

Authors:  Gang Hu; Johan Eriksson; Noël C Barengo; Timo A Lakka; Timo T Valle; Aulikki Nissinen; Pekka Jousilahti; Jaakko Tuomilehto
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

9.  Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland.

Authors:  M Laakso; T Rönnemaa; K Pyörälä; V Kallio; P Puukka; I Penttilä
Journal:  Diabetes Care       Date:  1988-06       Impact factor: 19.112

  9 in total
  1 in total

1.  Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes.

Authors:  Teemu Vepsäläinen; Minna Soinio; Jukka Marniemi; Seppo Lehto; Auni Juutilainen; Markku Laakso; Tapani Rönnemaa
Journal:  Diabetes Care       Date:  2011-05-20       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.